Year |
Citation |
Score |
2023 |
Weingarten-Gabbay S, Chen DY, Sarkizova S, Taylor HB, Gentili M, Hernandez GM, Pearlman LR, Bauer MR, Rice CM, Clauser KR, Hacohen N, Carr SA, Abelin JG, Saeed M, Sabeti PC. The HLA-II immunopeptidome of SARS-CoV-2. Cell Reports. 43: 113596. PMID 38117652 DOI: 10.1016/j.celrep.2023.113596 |
0.421 |
|
2023 |
Weingarten-Gabbay S, Chen DY, Sarkizova S, Taylor HB, Gentili M, Pearlman LR, Bauer MR, Rice CM, Clauser KR, Hacohen N, Carr SA, Abelin JG, Saeed M, Sabeti PC. The HLA-II immunopeptidome of SARS-CoV-2. Biorxiv : the Preprint Server For Biology. PMID 37398281 DOI: 10.1101/2023.05.26.542482 |
0.429 |
|
2023 |
Stražar M, Park J, Abelin JG, Taylor HB, Pedersen TK, Plichta DR, Brown EM, Eraslan B, Hung YM, Ortiz K, Clauser KR, Carr SA, Xavier RJ, Graham DB. HLA-II immunopeptidome profiling and deep learning reveal features of antigenicity to inform antigen discovery. Immunity. PMID 37301199 DOI: 10.1016/j.immuni.2023.05.009 |
0.458 |
|
2023 |
Phulphagar KM, Ctortecka C, Jacome ASV, Klaeger S, Verzani EK, Hernandez GM, Udeshi ND, Clauser KR, Abelin JG, Carr SA. Sensitive, high-throughput HLA-I and HLA-II immunopeptidomics using parallel accumulation-serial fragmentation mass spectrometry. Molecular & Cellular Proteomics : McP. 100563. PMID 37142057 DOI: 10.1016/j.mcpro.2023.100563 |
0.676 |
|
2023 |
Abelin JG, Bergstrom EJ, Rivera KD, Taylor HB, Klaeger S, Xu C, Verzani EK, Jackson White C, Woldemichael HB, Virshup M, Olive ME, Maynard M, Vartany SA, Allen JD, Phulphagar K, et al. Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues. Nature Communications. 14: 1851. PMID 37012232 DOI: 10.1038/s41467-023-37547-0 |
0.668 |
|
2023 |
Phulphagar KM, Ctortecka C, Vaca Jacome AS, Klaeger S, Verzani EK, Hernandez GM, Udeshi N, Clauser K, Abelin J, Carr SA. Sensitive, high-throughput HLA-I and HLA-II immunopeptidomics using parallel accumulation-serial fragmentation mass spectrometry. Biorxiv : the Preprint Server For Biology. PMID 36993564 DOI: 10.1101/2023.03.10.532106 |
0.676 |
|
2022 |
Weingarten-Gabbay S, Pearlman LR, Chen DY, Klaeger S, Taylor HB, Welch NL, Keskin DB, Carr SA, Abelin JG, Saeed M, Sabeti PC. HLA-I immunopeptidome profiling of human cells infected with high-containment enveloped viruses. Star Protocols. 3: 101910. PMID 36595954 DOI: 10.1016/j.xpro.2022.101910 |
0.316 |
|
2021 |
Choi J, Goulding SP, Conn BP, McGann CD, Dietze JL, Kohler J, Lenkala D, Boudot A, Rothenberg DA, Turcott PJ, Srouji JR, Foley KC, Rooney MS, van Buuren MM, Gaynor RB, ... Abelin JG, et al. Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutations. Cell Reports Methods. 1: 100084. PMID 35474673 DOI: 10.1016/j.crmeth.2021.100084 |
0.49 |
|
2021 |
Penny SA, Abelin JG, Malaker SA, Myers PT, Saeed AZ, Steadman LG, Bai DL, Ward ST, Shabanowitz J, Hunt DF, Cobbold M. Tumor Infiltrating Lymphocytes Target HLA-I Phosphopeptides Derived From Cancer Signaling in Colorectal Cancer. Frontiers in Immunology. 12: 723566. PMID 34504498 DOI: 10.3389/fimmu.2021.723566 |
0.775 |
|
2021 |
Klaeger S, Apffel A, Clauser KR, Sarkizova S, Oliveira G, Rachimi S, Le PM, Tarren A, Chea V, Abelin JG, Braun DA, Ott PA, Keshishian H, Hacohen N, Keskin DB, et al. Optimized liquid and gas phase fractionation increases HLA-peptidome coverage for primary cell and tissue samples. Molecular & Cellular Proteomics : McP. 100133. PMID 34391888 DOI: 10.1016/j.mcpro.2021.100133 |
0.323 |
|
2021 |
Weingarten-Gabbay S, Klaeger S, Sarkizova S, Pearlman LR, Chen DY, Gallagher KME, Bauer MR, Taylor HB, Dunn WA, Tarr C, Sidney J, Rachimi S, Conway HL, Katsis K, Wang Y, ... ... Abelin JG, et al. Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs. Cell. PMID 34171305 DOI: 10.1016/j.cell.2021.05.046 |
0.495 |
|
2021 |
Taylor HB, Klaeger S, Clauser KR, Sarkizova S, Weingarten-Gabbay S, Graham DB, Carr SA, Abelin JG. Mass spectrometry-based HLA-II peptidomics combined with multi-omics will aid the development of future immunotherapies. Molecular & Cellular Proteomics : McP. 100116. PMID 34146720 DOI: 10.1016/j.mcpro.2021.100116 |
0.538 |
|
2020 |
Weingarten-Gabbay S, Klaeger S, Sarkizova S, Pearlman LR, Chen DY, Bauer MR, Taylor HB, Conway HL, Tomkins-Tinch CH, Finkel Y, Nachshon A, Gentili M, Rivera KD, Keskin DB, Rice CM, ... ... Abelin JG, et al. SARS-CoV-2 infected cells present HLA-I peptides from canonical and out-of-frame ORFs. Biorxiv : the Preprint Server For Biology. PMID 33024965 DOI: 10.1101/2020.10.02.324145 |
0.466 |
|
2019 |
Abelin JG, Harjanto D, Malloy M, Suri P, Colson T, Goulding SP, Creech AL, Serrano LR, Nasir G, Nasrullah Y, McGann CD, Velez D, Ting YS, Poran A, Rothenberg DA, et al. Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction. Immunity. PMID 31495665 DOI: 10.1016/J.Immuni.2019.08.012 |
0.484 |
|
2018 |
Graham DB, Luo C, O'Connell DJ, Lefkovith A, Brown EM, Yassour M, Varma M, Abelin JG, Conway KL, Jasso GJ, Matar CG, Carr SA, Xavier RJ. Antigen discovery and specification of immunodominance hierarchies for MHCII-restricted epitopes. Nature Medicine. PMID 30349087 DOI: 10.1038/S41591-018-0203-7 |
0.519 |
|
2018 |
Creech AL, Ting YS, Goulding SP, Sauld JF, Barthelme D, Rooney MS, Addona TA, Abelin JG. The role of mass spectrometry and proteogenomics in the advancement of HLA epitope prediction. Proteomics. PMID 29314742 DOI: 10.1002/pmic.201700259 |
0.321 |
|
2017 |
Abelin JG, Keskin DB, Sarkizova S, Hartigan CR, Zhang W, Sidney J, Stevens J, Lane W, Zhang GL, Eisenhaure TM, Clauser KR, Hacohen N, Rooney MS, Carr SA, Wu CJ. Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction. Immunity. 46: 315-326. PMID 28228285 DOI: 10.1016/J.Immuni.2017.02.007 |
0.309 |
|
2016 |
Ager C, Reilley M, Nicholas C, Bartkowiak T, Jaiswal A, Curran M, Albershardt TC, Bajaj A, Archer JF, Reeves RS, Ngo LY, Berglund P, ter Meulen J, Denis C, Ghadially H, ... ... Abelin JG, et al. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two Journal For Immunotherapy of Cancer. 4. DOI: 10.1186/S40425-016-0173-6 |
0.491 |
|
2016 |
Penny S, Abelin J, Saeed A, Malaker S, Trantham P, Shabanowitz J, Ward S, Hunt D, Cobbold M. Phosphopeptides as novel tumour antigens in colorectal cancer European Journal of Cancer. 61: S213. DOI: 10.1016/S0959-8049(16)61751-3 |
0.522 |
|
2015 |
Abelin JG, Trantham PD, Penny SA, Patterson AM, Ward ST, Hildebrand WH, Cobbold M, Bai DL, Shabanowitz J, Hunt DF. Complementary IMAC enrichment methods for HLA-associated phosphopeptide identification by mass spectrometry. Nature Protocols. 10: 1308-18. PMID 26247297 DOI: 10.1038/Nprot.2015.086 |
0.677 |
|
2014 |
Penny SA, Abelin JG, Saeed AZ, Malaker SA, Trantham PD, Shabanowitz J, Ward ST, Hunt DF, Cobbold M. Abstract 3627: Phosphopeptides as novel T cell epitopes in colorectal cancer Cancer Research. 74: 3627-3627. DOI: 10.1158/1538-7445.Am2014-3627 |
0.769 |
|
2013 |
Cobbold M, De La Peña H, Norris A, Polefrone JM, Qian J, English AM, Cummings KL, Penny S, Turner JE, Cottine J, Abelin JG, Malaker SA, Zarling AL, Huang HW, Goodyear O, et al. MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia. Science Translational Medicine. 5: 203ra125. PMID 24048523 DOI: 10.1126/Scitranslmed.3006061 |
0.314 |
|
Show low-probability matches. |